Roger D Tung - Chief Executive Officer, Concert Pharmaceuticals, Inc

As of March 16, 2020


What is Roger D Tung's Net Worth?

The current estimated net worth of Concert Pharmaceuticals, Inc's Chief Executive Officer, Roger D Tung, is estimated to be about $3.63M . Roger D Tung owns about 551,354 units of Concert Pharmaceuticals, Inc common stock. In the last 6 years at Concert Pharmaceuticals, Inc, Roger D Tung has sold an estimated value of $391.15K worth.

What is Roger D Tung's Past Insider Trading?

Roger D Tung's largest purchase order was 19,610 units , worth over $206.89K on May 12, 2016. In total, Roger D Tung has made about 20 transactions over 6 years of their time at Concert Pharmaceuticals, Inc. Roger D Tung usually trades in January, with the busiest year in 2019.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Roger D Tung's Salary in 2020?

As Chief Executive Officer of Concert Pharmaceuticals, Inc, Roger D Tung has a total base salary of $581,967 . Roger D Tung received compensation valued at about $3,024,777 in 2020 after becoming Chief Executive Officer. The vast majority of their compensation came in the form of option awards of $1,011,657 , stock awards of $1,098,957 , other earnings, plans or compensations of $320,082 , and other compensation of $12,114 .

What is Roger D Tung's' Mailing Address?

  • Mailing address is 99 Hayden Avenue, Suite 500 Lexington MA 02421 MA

Concert Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Stock Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Roger D. Tung 2020 $581,967 - $1,011,657 $1,098,957 $320,082 $12,114 $3,024,777
Roger D. Tung 2019 $562,287 - $1,889,500 - $309,258 $11,304 $2,772,349
James V. Cassella 2020 $450,633 - $283,144 $306,708 $225,317 $15,408 $1,281,210
James V. Cassella 2019 $435,394 - $708,563 $319,397 $217,697 $13,988 $1,695,039
Nancy Stuart 2020 $444,530 - $455,212 $493,096 $177,812 $12,114 $1,582,764
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1367920/000136792021000022/a2021proxy.htm

What are Concert Pharmaceuticals, Inc's Past Insider Trades?

Concert Pharmaceuticals, Inc's most recent insider trade came on June 6, 2022 by Christi Heek Van who bought 10,526 units worth $50K . In the last 8 years, insiders at Concert Pharmaceuticals, Inc have sold an estimated value of $71.76M and bought an estimated value of $26.81M worth of shares. Insider trading is most common in June, with the busiest year in 2015 and 2018. The most active traders at the company are Nancy Stuart, Chief Operating Officer,  Roger Tung, Chief Executive Officer,  and Richard Aldrich, Director .

CONCERT PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1